International uniting seven laboratory networks (e.g. PulseNet USA and PulseNet Europe). Later, the original protocol A was optimized and dispatched in 2009 by the European Union Reference Laboratory (EURL) to the participant European laboratories as the EURL in-house method [B1] . It was similar to the updated PulseNet USA PFGE standardized protocol [B2] published soon a er (Halpin et al., 2010) . Major di erences between the two were presented previously (Félix et al., 2012) . In brief, the B2 protocol, in comparison to B1, reco mmends lower cell density per PFGE plug, the preparation of lysozyme solution in TE bu er (vs. water) and incubation at 56°C (vs. 37°C), and higher amount of the restriction enzymes and the total volume of restriction mixtures (200 μl vs. 100 μl). In comparison to A, both B1 and B2 protocols recommend a much lower amount of ApaI in the restriction digests, namely 10 U (B1) and 50 U (B2) in comparison to the original 160-200 U (A) per sample, and the addition of bovine serum albumin (BSA) to the restriction mixtures even when not recommended by the manufacturer.
e aim of the present paper was to present how the selection of di erent suppliers/protocols ApaI restriction can a ect the quality of L. monocytogenes ApaI pulsotypes, exerting higher complexity (14-17 bands expected) than AscI profiles (6-12; Carriere et al., 1991) . In our study, PFGE employing restriction enzyme ApaI was performed as recommended by the original protocol A. As a molecular size-marker, Salmonella enterica serovar Braenderup (strain H9812, digested with XbaI) was used (Hunter et al., 2005) . Electrophoresis was performed on CHEF-DR II apparatus (BioRad, Hercules, CA, USA). ree di erent ApaI enzymes were compared. First, ApaI from Roche Diagnostics [RD] (Mannheim, Germany) with 40 U/μl stock concentration and the optimal incubation temperature of 30°C, since recommended in A and B1 (and in B2 as the protocol refers to A regarding the restriction enzymes). Second, ApaI from ermo Fischer Scientific [TS] (Waltham, MA, USA; formerly purchased under a trademark of Fermentas, Vilnius, Lithuania) with 10 U/μl concentration and 37°C incubation temperature, since manufactured by an established company in the field of restriction enzymes. ird, ApaI from New England BioLabs [NEB] (Ipswich, MA, USA) with 50 U/μl concentration and 25°C incubation temperature, since recommended for AscI restriction in A and B1. No separately purchased BSA was included in any of the ApaI restriction mixtures as not yet recommended in A; BSA is, however, already present in the restriction bu er from TS and supplied separately with ApaI (but not with AscI) enzyme from NEB. Since given as a potential stopping point, incubation of PFGE plugs in TE bu er (0.01 M Tris-EDTA, pH 8.0) was tested a er restriction using ApaI from NEB, namely the restriction mixture was removed and replaced by equal volume of TE for an overnight (one-day) incubation of plugs at 4°C (Cooper, 2010) .
Selection of ApaI restriction enzymes purchased from di erent manufacturers can a ect the quality of L. monocytogenes pulsotypes. ApaI from RD has been employed for several years in our laboratory, namely since 2006 when we started the PFGE typing of L. monocytogenes following the protocol A, and we have been obtaining good-quality results (Fig. 1a) . Later, ApaI from TS was tested and it also generated pulsotypes of satisfactory quality (Fig. 1b, lanes 3 and 4) ; however, the volume of enzyme solution needed for the preparation of restriction mixture was higher in comparison to ApaI from RD due to a lower concentration of the enzyme available from TS. is can be acknowledged as a drawback due to two aspects. First, since glycerol is present in the storage bu er of enzymes, larger consumption of enzyme solution leads to a higher glycerol concentration in the restriction mixture, possibly conditioning the star activity of restriction enzymes (Freeman, 2011) . Second, larger consumption demands for larger enzyme stocks.
erefore, an enzyme with higher concentration was tested, namely ApaI from NEB. In comparison to RD and TS, NEB enzyme generated poor-quality pulsotypes (Fig. 1b, lanes 1 and 2; Fig. 1c) . However, when an overnight TE-incubation of plugs a er restriction was tested, the obtained pulsotypes markedly improved (Fig. 1d) .
It had been shown before that enzyme digestion was not optimal when e.g. BSA was not included in the restriction mixture, not enough or too many units of restriction enzyme were used, and incubation time, Fig. 1 . PFGE separation of ApaI fragments from L. monocytogenes isolates. Salmonella Braenderup strain H9812 (SB) was employed as size standard.
(a) ApaI from Roche Diagnostics, isolates 1-4; (b) ApaI from New England BioLabs (NEB; lanes 1 and 2) and from ermo Fischer Scientific (lanes 3 and 4), isolates 5 and 6; (c) ApaI from NEB, isolates 1-3 and 7; (d) ApaI from NEB followed by an overnight incubation in TE bu er, isolates 8-11 (8 and 11 showed an identical pulsotype as isolate 2, and 10 identical as isolate 3, as indicated in the parentheses)
temperature or bu er were not correct (Freeman, 2011) . However, in the case of ApaI from NEB in our study, digestion did not seem to be compromised in such manner as the number of bands, appearance of ghost/ shadow bands, resolution or high background could not be discussed as a main problem. Band distortion was a much more serious issue impairing the pulsotype quality and interpretation. Wavy bands, as seen in Figs. 1b and 1c, were observed before in plugs digested with ApaI from NEB, in the presence of BSA and with di erent laboratory personnel (Freeman, 2012) . It was concluded that band distortion could be directly correlated with the units of restriction enzyme added to the master mix, namely an increasing distortion was observed when 100 or more U of ApaI were employed (in our study, 200 U were added according to the original protocol A). Moreover, the anomaly was observed with new enzyme lots in January 2012 (Freeman, 2012) . In our study, ApaI with a lot number higher from the ones tested by Freeman (2012) was used, assuming the enzyme was also released in January 2012 or later. It can be concluded that variations in the standardized PFGE protocols can, among other reasons discussed elsewhere like the quality of water, in-house prepared bu ers, laboratory personnel or others, appear due to the lot-to-lot variations of restriction enzymes from the same manufacturer or between enzymes from di erent manufacturers. e EURL in-house method for the PFGE typing of L. monocytogenes (protocol B1) recommends the use of AscI from NEB, but ApaI from RD, and comments that the use of materials and reagents of other suppliers could generate deviation in the results. It was also recommended (protocols B1 and B2) that the amount of restriction enzymes, especially of ApaI, should not be in excess when aiming for pulsotypes of high quality. In other studies, an overnight (or longer) incubation in TE bu er was not suggested as a curative step in the protocol of ApaI restriction; however, improved the quality of pulsotypes obtained in our study when testing ApaI from NEB.
